Hepatitis Weekly
Susan Hasty, Publisher
Table of Contents . . . July 14th, 2003
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Chronic Hepatitis C - Hepatitis C therapy regresses fibrosis even when viral response is elusive
Kidney Transplant - Hepatitis B virus gene deletions alter outcomes for renal recipients
Chronic Hepatitis B - A new immunoassay presents a simple way to monitor hepatitis B virus patients
Chronic Hepatitis C - Eicosapentaenoic acid ameliorates ribavirin-related anemia
Genome Modeling - Transfected murine NIH/3T3 cells express the hepatitis C virus receptor CD81
Virology - Characterization of hepatitis B conformational epitopes sheds light on affinity
Animal Research - Tree shrews could model a number of chronic and infectious human diseases
Cancer Risk Factor - Codon 72 polymorphism on the p53 gene doesn't raise liver cancer risk
Critical Care Medicine - Anti-inflammatory compound enters Phase I clinical trial
Hematology - Interferon causes life-threatening thrombocytopenia in a hepatitis C patient
Hepatitis C Therapy - Study finds IFN-alpha not as effective for African Americans as Caucasians
Hepatology - Biopsy distinguishes simple fatty liver from non-alcoholic steatohepatitis
Leukemia - Rare autoimmune hepatitis follows stem cell transplantation from a sibling
Lipid Studies - High-density lipoprotein binding rates in hepatitis C virus genotypes diverge
Liver Cancer - TRAIL gene therapy for hepatocellular carcinoma calls for a stringent protocol
Liver Dysfunction - Insulin use leads to water retention in a patient with autoimmune hepatitis
Mutagenesis - Keratin 8 and 18 mutations heighten susceptibility to liver cancer formation
Oncology - M6P/IGF2R expression loss, not mutation, marks hepatitis B virus-related cancer
Transfusion-Transmitted Virus - Host elements factor into the viremia of TT virus
Viral Proteomics - Hepatitis C virus NS5A protein inhibits protein-1 activation through Ras-ERK
Viral hepatitis - Combination therapies have improved prospects for chronic hepatitis patients
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
